Biblio

Found 32 results
Filters: Keyword is Narcolepsy  [Clear All Filters]
2015
Shan L, Dauvilliers Y, Siegel JM.  2015.  Interactions of the histamine and hypocretin systems in CNS disorders.. Nature Reviews Neurology. 11(7):401-13.
2014
Kostin A, Siegel JM, Alam MNoor.  2014.  Lack of hypocretin attenuates behavioral changes produced by glutamatergic activation of the perifornical-lateral hypothalamic area.. Sleep. 37(5):1011-20.
2013
John J, Thannickal TC, McGregor R, Ramanathan L, Ohtsu H, Nishino S, Sakai N, Yamanaka A, Stone C, Cornford M et al..  2013.  Greatly increased numbers of histamine cells in human narcolepsy with cataplexy.. Annals of Neurology. 74(6):786-93.
2012
Scammell TE, Matheson JK, Honda M, Thannickal TC, Siegel JM.  2012.  Coexistence of narcolepsy and Alzheimer's disease.. Neurobiol Aging. 33(7):1318-9.
2011
Siegel JM.  2011.  REM sleep: a biological and psychological paradox.. Sleep Med Rev. 15(3):139-42.
2009
Scammell TE, Willie JT, Guilleminault C, Siegel JM.  2009.  A consensus definition of cataplexy in mouse models of narcolepsy.. Sleep. 32(1):111-6.
Thannickal TC, Nienhuis R, Siegel JM.  2009.  Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.. Sleep. 32(8):993-8.
Siegel JM.  2009.  Narcolepsy. Interview by Norman Sussman.. CNS Spectr. 14(6):295-7.
Siegel JM.  2009.  The neurobiology of sleep.. Semin Neurol. 29(4):277-96.
2008
Siegel JM.  2008.  Gaps that wake you up.. Sleep. 31(12):1625-6.
Thannickal TC, Lai Y-Y, Siegel JM.  2008.  Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease.. Brain. 131(Pt 1):e87.
2006
Siegel JM, Boehmer LN.  2006.  Narcolepsy and the hypocretin system--where motion meets emotion.. Nature Clinical Practice Neurology [Nature Reviews Neurology]. 2(10):548-56.
2005
Blouin AM, Thannickal TC, Worley PF, Baraban JM, Reti IM, Siegel JM.  2005.  Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.. Neurology. 65(8):1189-92.
2004
Siegel JM.  2004.  Hypocretin (orexin): role in normal behavior and neuropathology.. Annual Reviews of Psychology. 55:125-48.
2003
Thannickal TC, Siegel JM, Nienhuis R, Moore RY.  2003.  Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.. Brain Pathology. 13(3):340-51.
2001
Siegel JM, Moore R, Thannickal T, Nienhuis R.  2001.  A brief history of hypocretin/orexin and narcolepsy.. Neuropsychopharmacology. 25(5 Suppl):S14-20.
2000
Thannickal TC, Moore RY, Aldrich M, Albin R, Cornford M, Siegel JM.  2000.  First report of hypocretin (orexin) neuron loss in human narcolepsy: "Human narcolepsy is linked to reduced number, size and synaptic bouton density in hypocretin-2 labeled neurons.". Society for Neuroscience, submitted March 5. 25
Siegel JM.  2000.  Narcolepsy. Scientific American. 282
Siegel JM.  2000.  Recent developments in narcolepsy research, an explanation for patients and the general public. Narcolepsy Network Newsletter. :1-2.
Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM.  2000.  Reduced number of hypocretin neurons in human narcolepsy.. Neuron. 27(3):469-74.
John J, Wu MF, Siegel JM.  2000.  Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs.. Sleep Res Online. 3(1):23-8.
1999
Siegel JM.  1999.  Narcolepsy: a key role for hypocretins (orexins). Cell. 98(4):409-12.
Siegel JM, Nienhuis R, Gulyani S, Ouyang S, Wu MF, Mignot E, Switzer RC, McMurry G, Cornford M.  1999.  Neuronal degeneration in canine narcolepsy.. J Neurosci. 19(1):248-57.
1995
Nitz D, Andersen A, Fahringer H, Nienhuis R, Mignot E, Siegel J.  1995.  Altered distribution of cholinergic cells in the narcoleptic dog.. Neuroreport. 6(11):1521-4.
Nishino S, Tafti M, Reid MS, Shelton J, Siegel JM, Dement WC, Mignot E.  1995.  Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy.. J Neurosci. 15(7 Pt 1):4806-14.

Pages